ArticleCancer cell2023

Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma.

Katie M Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.